Literature DB >> 27326911

Descriptors and their selection methods in QSAR analysis: paradigm for drug design.

Asad U Khan1.   

Abstract

The screening of chemical libraries with traditional methods, such as high-throughput screening (HTS), is expensive and time consuming. Quantitative structure-activity relation (QSAR) modeling is an alternative method that can assist in the selection of lead molecules by using the information from reference active and inactive compounds. This approach requires good molecular descriptors that are representative of the molecular features responsible for the relevant molecular activity. The usefulness of these descriptors in QSAR studies has been extensively demonstrated, and they have also been used as a measure of structural similarity or diversity. In this review, we provide a brief explanation of descriptors and the selection approaches most commonly used in QSAR experiments. In addition, some studies have also demonstrated the positive influence of features selection for any drug development model.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27326911     DOI: 10.1016/j.drudis.2016.06.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  38 in total

Review 1.  Big-Data Science in Porous Materials: Materials Genomics and Machine Learning.

Authors:  Kevin Maik Jablonka; Daniele Ongari; Seyed Mohamad Moosavi; Berend Smit
Journal:  Chem Rev       Date:  2020-06-10       Impact factor: 60.622

2.  Prediction of protein corona on nanomaterials by machine learning using novel descriptors.

Authors:  Yaokai Duan; Roxana Coreas; Yang Liu; Dimitrios Bitounis; Zhenyuan Zhang; Dorsa Parviz; Michael Strano; Philip Demokritou; Wenwan Zhong
Journal:  NanoImpact       Date:  2020-01-16

3.  Influence of feature rankers in the construction of molecular activity prediction models.

Authors:  Gonzalo Cerruela-García; José Pérez-Parra Toledano; Aída de Haro-García; Nicolás García-Pedrajas
Journal:  J Comput Aided Mol Des       Date:  2019-12-31       Impact factor: 3.686

Review 4.  Machine learning in chemoinformatics and drug discovery.

Authors:  Yu-Chen Lo; Stefano E Rensi; Wen Torng; Russ B Altman
Journal:  Drug Discov Today       Date:  2018-05-08       Impact factor: 7.851

5.  Simulating drug concentrations in PDMS microfluidic organ chips.

Authors:  Jennifer Grant; Alican Özkan; Crystal Oh; Gautam Mahajan; Rachelle Prantil-Baun; Donald E Ingber
Journal:  Lab Chip       Date:  2021-09-14       Impact factor: 7.517

6.  Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.

Authors:  Kushagra Kashyap; Mohammad Imran Siddiqi
Journal:  Mol Divers       Date:  2021-07-19       Impact factor: 3.364

7.  Molecular Topology for the Search of New Anti-MRSA Compounds.

Authors:  Jose I Bueso-Bordils; Pedro A Alemán-López; Rafael Martín-Algarra; Maria J Duart; Antonio Falcó; Gerardo M Antón-Fos
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

8.  A deep learning approach to predict blood-brain barrier permeability.

Authors:  Shrooq Alsenan; Isra Al-Turaiki; Alaaeldin Hafez
Journal:  PeerJ Comput Sci       Date:  2021-06-10

Review 9.  Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.

Authors:  José T Moreira-Filho; Arthur C Silva; Rafael F Dantas; Barbara F Gomes; Lauro R Souza Neto; Jose Brandao-Neto; Raymond J Owens; Nicholas Furnham; Bruno J Neves; Floriano P Silva-Junior; Carolina H Andrade
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

10.  A perspective on multi-target drug discovery and design for complex diseases.

Authors:  Rona R Ramsay; Marija R Popovic-Nikolic; Katarina Nikolic; Elisa Uliassi; Maria Laura Bolognesi
Journal:  Clin Transl Med       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.